MSB 5.12% $1.39 mesoblast limited

Cell Therapy News/Articles, page-16489

  1. 15,671 Posts.
    lightbulb Created with Sketch. 5726

    Do we have access to the data?


    I would have thought you would have had access to this EAP data given your definitive statements on the BLA resubmission ‘supposedly’ being deficient in its response to the CRL … oh wait
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.